Company Profiles

driven by the PitchBook Platform

Exela Pharma Sciences

Description

Developer and manufacturer of innovative and generic injectable, ophthalmic and inhalation pharmaceutical products. The company conducts research to produce non-infringing but therapeutically effective formulations that are scaled up by the company, or by one of its strategic partners. The formulations provide products that could be marketed as generic or brand alternatives to currently marketed products. The company also works on new molecules and dosage forms intended to increase available treatment choices to physicians while improving patients’ quality of life and treatment experience.

2007

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$420k

Latest Deal Amount

$11.6M

Total Amount Raised

Description

Developer and manufacturer of innovative and generic injectable, ophthalmic and inhalation pharmaceutical products. The company conducts research to produce non-infringing but therapeutically effective formulations that are scaled up by the company, or by one of its strategic partners. The formulations provide products that could be marketed as generic or brand alternatives to currently marketed products. The company also works on new molecules and dosage forms intended to increase available treatment choices to physicians while improving patients’ quality of life and treatment experience.

Website:

www.exelapharma.com

Formerly Known As

Galexe Pharma Sciences, Exela Holdings

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals

Primary Office

1245 Blowing Rock Boulevard Lenoir, NC 28645United States +1 (888) 451-4321
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Exela Pharma Sciences's full profile, request a free trial.

Exela Pharma Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Exela Pharma Sciences Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Presidio PartnersVenture CapitalMinority000 0000000 0000
Presidio Partners Venture Capital

Exela Pharma Sciences Executive Team (7)

NameTitleBoard
Seat
Contact
Info
SR Murthy Mallipeddi Ph.DChief Scientific Officer & Co-Founder
Mark HartmanChief Commercial Officer
Phanesh Koneru Ph.DCo-Founder, Director, President & Chief Executive Officer
Jonathan SterlingVice President of Quality & Regulatory
Daniel RingVice President, Business Development & Licensing
SR Murthy Mallipeddi Ph.D Chief Scientific Officer & Co-Founder
Mark Hartman Chief Commercial Officer
Phanesh Koneru Ph.D Co-Founder, Director, President & Chief Executive Officer
Jonathan Sterling Vice President of Quality & Regulatory
Daniel Ring Vice President, Business Development & Licensing

Exela Pharma Sciences Board Members (3)

NameRepresentingRoleSinceContact
Info
Michael Melnick Ph.DPresidio PartnersBoard Observer000 0000
Phanesh Koneru Ph.DExela Pharma SciencesCo-Founder, Director, President & Chief Executive Officer000 0000
Thomas Baruch JDPresidio PartnersBoard Member000 0000
Michael Melnick Ph.D Board Observer Presidio Partners
Phanesh Koneru Ph.D Co-Founder, Director, President & Chief Executive Officer Exela Pharma Sciences
Thomas Baruch JD Board Member Presidio Partners
Request full access to PitchBook